A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors

Clinical trial NCT05001347 · COMPLETED

Trial details

NCT number: NCT05001347
Sponsor: I-Mab Biopharma US Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Head and Neck Cancer Non Small Cell Lung Cancer Gastrointestinal Cancer Triple Negative Breast Cancer Ovarian Carcinoma

Start date: 2021-11-02
Primary completion: 2023-02-08
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.